2m 2m 2m 2m 2m 2m 2m
Chemed (CHE)
NYSE
$441.11+$5.04 (+1.15%)
Price as of Jun 23, 2026 5:39 PM EDT- $5.8BMarket Cap
- -20.51%1-Year Change
- Medical Care FacilitiesIndustry
Chemed (CHE)
$441.11+$5.04 (+1.15%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.5B +4.06% | 2.4B +7.37% | 2.3B +6.06% | 2.1B -0.20% | |
Cost of Revenue | 1.7B +8.23% | 1.6B +7.60% | 1.5B +6.99% | 1.4B +0.03% | |
Gross Profit | 823.2M -3.65% | 854.3M +6.95% | 798.8M +4.41% | 765.1M -0.61% | |
Sales and Marketing Expense | 417.2M -1.69% | 424.4M +7.40% | 395.1M +10.15% | 358.7M -2.18% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 64.8M +2.84% | 63.0M +3.59% | 60.9M +2.86% | 59.2M +0.20% | |
Total Operating Expenses | 2.2B +6.15% | 2.1B +7.33% | 1.9B +7.39% | 1.8B -0.26% | |
Operating Profit | 338.2M -7.71% | 366.5M +7.61% | 340.6M -0.85% | 343.5M +0.13% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.8M -1.69% | -1.8M -42.73% | -3.1M -32.20% | -4.6M +145.40% | |
Interest Income and Expense and Net | -1.8M -1.69% | -1.8M -42.73% | -3.1M -32.20% | -4.6M +145.40% | |
Total Nonoperating Income and Expense | 19.3M -44.52% | 34.8M +169.27% | 12.9M +239.78% | -9.2M -200.97% | |
Income before Taxes | 355.8M -10.94% | 399.5M +14.01% | 350.4M +6.28% | 329.7M -5.89% | |
Income Taxes | 90.5M -7.11% | 97.5M +25.18% | 77.9M -2.74% | 80.1M -2.09% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | 302.0M +10.82% | 272.5M +9.17% | 249.6M -7.05% | |
Net Income from Continuing Operations Applicable to Common | 355.8M -10.94% | 399.5M +14.01% | 350.4M +6.28% | 329.7M -5.89% | |
Basic EPS and Net Income | 18.42 -8.36% | 20.10 +10.99% | 18.11 +8.31% | 16.72 -2.45% | |
Diluted EPS and Net Income | 18.34 -7.79% | 19.89 +10.93% | 17.93 +8.47% | 16.53 -1.90% | |
Basic Weighted Average Shares | 14.4M -4.17% | 15.0M -0.17% | 15.1M +0.81% | 14.9M -4.73% | |
Diluted Weighted Average Shares | 14.5M -4.78% | 15.2M -0.09% | 15.2M +0.67% | 15.1M -5.26% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 74.5M -58.22% | 178.3M -32.43% | 264.0M +256.09% | 74.1M +125.34% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 74.5M -58.22% | 178.3M -32.43% | 264.0M +256.09% | 74.1M +125.34% | |
Total Current Assets | 302.6M -23.34% | 394.7M -21.18% | 500.8M +83.72% | 272.6M +18.38% | |
Accumulated Depreciation | 388.1M +1.60% | 382.0M +7.64% | 354.9M +5.64% | 335.9M +5.66% | |
Property and Plant and Equipment and Net | 205.7M +2.40% | 200.8M -1.47% | 203.8M +2.07% | 199.7M +3.12% | |
Total Long-Term Assets | 8.7M -84.49% | 55.8M +0.25% | 55.6M -7.00% | 59.8M +634.91% | |
Total Assets | 1.5B -7.81% | 1.7B +0.03% | 1.7B +15.68% | 1.4B +7.39% | |
Income Taxes Payable | 21.8M -34.95% | 33.5M -9.79% | 37.2M -3.82% | 38.7M +66.44% | |
Total Short-Term Debt | N/A N/A | 100.0M +1,900.00% | 5.0M 0.00% | 5.0M N/A | |
Total Current Liabilities | 287.1M +0.50% | 285.7M -8.45% | 312.1M +4.99% | 297.2M -1.72% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 92.5M 0.00% | 92.5M -50.00% | |
Total Long-Term Liabilities | 13.3M -0.25% | 13.4M +2.81% | 13.0M +7.14% | 12.1M +25.87% | |
Total Liabilities | 558.8M +1.67% | 549.6M -1.90% | 560.2M -12.91% | 643.3M -10.58% | |
Retained Earnings | 3.0B +8.58% | 2.7B +11.23% | 2.4B +11.33% | 2.2B +11.55% | |
Total Stockholders Equity | 979.4M -12.47% | 1.1B +1.00% | 1.1B +38.71% | 798.7M +28.15% | |
Total Shares Outstanding | 37.6M +0.46% | 37.4M +0.64% | 37.2M +1.05% | 36.8M +0.77% | |
Cash Flow | |||||
Cash from Operating Activities | 388.3M -7.00% | 417.5M +26.40% | 330.3M +6.59% | 309.9M +0.42% | |
Capital Expenditures | 62.8M +26.78% | 49.5M -12.88% | 56.9M -0.82% | 57.3M -2.30% | |
Cash from Investing Activities | -59.3M -58.77% | -143.9M +137.31% | -60.6M +2.09% | -59.4M +2.85% | |
Dividends Paid | 31.7M +16.99% | 27.1M +15.28% | 23.5M +6.74% | 22.0M +0.005% | |
Cash from Financing Activities | -432.8M +20.48% | -359.2M +349.98% | -79.8M -61.85% | -209.3M -45.02% | |
Financials Ratio | |||||
Gross Margin | 32.54% -7.41% | 35.14% -0.39% | 35.28% -1.56% | 35.84% -0.41% | |
Operating Margin | 13.37% -11.31% | 15.07% +0.23% | 15.04% -6.52% | 16.09% +0.33% | |
Return on Assets | N/A N/A | 18.10% +3.30% | 17.52% -2.25% | 17.93% -7.28% | |
Return on Equity | N/A N/A | 27.12% -5.12% | 28.59% -18.58% | 35.11% -0.35% | |
Revenue Growth | 4.06% -44.92% | 7.37% +21.53% | 6.06% +3,118.17% | -0.20% -107.00% | |
Current Ratio | 1.05 -23.72% | 1.38 -13.91% | 1.61 +74.97% | 0.92 +20.46% | |
Cash Ratio | 0.26 -58.43% | 0.62 -26.20% | 0.85 +239.17% | 0.25 +129.23% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.09 -27.93% | 0.12 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.06 -13.61% | 0.07 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow